160 related articles for article (PubMed ID: 27123931)
1. Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease.
Blackledge MD; Tunariu N; Orton MR; Padhani AR; Collins DJ; Leach MO; Koh DM
PLoS One; 2016; 11(4):e0153840. PubMed ID: 27123931
[TBL] [Abstract][Full Text] [Related]
2. Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study.
Blackledge MD; Collins DJ; Tunariu N; Orton MR; Padhani AR; Leach MO; Koh DM
PLoS One; 2014; 9(4):e91779. PubMed ID: 24710083
[TBL] [Abstract][Full Text] [Related]
3. Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases.
Donners R; Candito A; Blackledge M; Rata M; Messiou C; Koh DM; Tunariu N
Br J Radiol; 2023 Nov; 96(1151):20230378. PubMed ID: 37660399
[TBL] [Abstract][Full Text] [Related]
4. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
[TBL] [Abstract][Full Text] [Related]
5. Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals.
Donners R; Yiin RSZ; Koh DM; De Paepe K; Chau I; Chua S; Blackledge MD
Quant Imaging Med Surg; 2021 Aug; 11(8):3549-3561. PubMed ID: 34341730
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement.
Bernardin L; Douglas NH; Collins DJ; Giles SL; O'Flynn EA; Orton M; deSouza NM
Eur Radiol; 2014 Feb; 24(2):502-11. PubMed ID: 24275802
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements.
Priola AM; Priola SM; Gned D; Giraudo MT; Brundu M; Righi L; Veltri A
J Magn Reson Imaging; 2017 Sep; 46(3):769-782. PubMed ID: 28117923
[TBL] [Abstract][Full Text] [Related]
9. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images: differences according to the types of primary tumour, the affected bones, and clinical factors.
Cha MJ; Yoon YC
Clin Radiol; 2015 Oct; 70(10):1116-21. PubMed ID: 26145186
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Whole-Body Diffusion-Weighted MR Imaging.
Donners R; Blackledge M; Tunariu N; Messiou C; Merkle EM; Koh DM
Magn Reson Imaging Clin N Am; 2018 Nov; 26(4):479-494. PubMed ID: 30316462
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient measurements in diffusion-weighted magnetic resonance imaging of the anterior mediastinum: inter-observer reproducibility of five different methods of region-of-interest positioning.
Priola AM; Priola SM; Parlatano D; Gned D; Giraudo MT; Giardino R; Ferrero B; Ardissone F; Veltri A
Eur Radiol; 2017 Apr; 27(4):1386-1394. PubMed ID: 27516357
[TBL] [Abstract][Full Text] [Related]
13. Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate Cancer.
Donners R; Candito A; Rata M; Sharp A; Messiou C; Koh DM; Tunariu N; Blackledge MD
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730599
[TBL] [Abstract][Full Text] [Related]
14. Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification.
Mainenti PP; Pizzuti LM; Segreto S; Comerci M; Fronzo S; Romano F; Crisci V; Smaldone M; Laccetti E; Storto G; Alfano B; Maurea S; Salvatore M; Pace L
Eur J Radiol; 2016 Jan; 85(1):113-124. PubMed ID: 26724655
[TBL] [Abstract][Full Text] [Related]
15. Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses.
Ponhold L; Javor D; Heinz-Peer G; Sevcenco S; Hofstetter M; Baltzer PA
Acta Radiol; 2016 Aug; 57(8):1014-20. PubMed ID: 26486599
[TBL] [Abstract][Full Text] [Related]
16. Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
Zhang KS; Neelsen CJO; Wennmann M; Glemser PA; Hielscher T; Weru V; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
Eur J Radiol; 2023 Aug; 165():110898. PubMed ID: 37331287
[TBL] [Abstract][Full Text] [Related]
17. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
18. Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.
Perez-Lopez R; Lorente D; Blackledge MD; Collins DJ; Mateo J; Bianchini D; Omlin A; Zivi A; Leach MO; de Bono JS; Koh DM; Tunariu N
Radiology; 2016 Jul; 280(1):151-60. PubMed ID: 26807894
[TBL] [Abstract][Full Text] [Related]
19. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
Pricolo P; Ancona E; Summers P; Abreu-Gomez J; Alessi S; Jereczek-Fossa BA; De Cobelli O; Nolè F; Renne G; Bellomi M; Padhani AR; Petralia G
Cancer Imaging; 2020 Oct; 20(1):77. PubMed ID: 33109268
[TBL] [Abstract][Full Text] [Related]
20. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
